Register by May 7
Join West Virginia Clinical and Translational Science Institute leadership and members from across the state to discuss exciting new efforts and initiatives in clinical and translational science in the Mountain State.
This day-and-a-half event will feature: WVCTSI progress and highlights, research roundtable discussions, presentations from team science headliners, innovation and commercialization pitches in the WVCTSI Shark Tank, poster presentations from exciting work across the CTS spectrum, updates on available resources and services for members, and breakout sessions on key topics and trends.
This meeting will also feature a keynote address from Sten Vermund, M.D., Ph.D., Dean and Anna M.R. Lauder Professor of Public Health at Yale School of Public Health and professor of pediatrics at the Yale School of Medicine.
The meeting will be held May 16 – 17 at the Morgantown Marriott at Waterfront Place in Morgantown, West Virginia. Deadline to register for this event is 11:59 p.m. EST on Monday, May 7. Additional information and registration can be found on the event webpage.
W est Virginia University’s Cancer Institute is well-known for its treatment and innovation. Leading the institute is Dr. Richard Goldberg, who has not only established himself as a transformative leader but also a potent researcher and educator. A native of upstate New York, the renowned gastrointestinal cancer expert came to Morgantown about two years ago. Goldberg previously worked at The Ohio State University’s Wexner Medical Center, where he served as the Klotz Family Professor of Cancer Research, the physician‐in‐ chief of the James Cancer Hospital, the associate director of the Ohio State Comprehensive Cancer Center and the acting division director of the Division of Medical Oncology. Before that, he also worked at the University of North Carolina and the Mayo Clinic. Goldberg is one of many world-class physicians recruited by WVU Medicine during the past few years, whose research has resulted in more than 300 peer-reviewed publications, including those in the New England Journal of Medicine, the Journal of the American Medical Association and the Journal of Clinical Oncology
The WVU Cancer Institute is among six organizations to receive an inaugural Medline Breast Cancer Awareness grant, which is awarded to organizations to further the mission to eradicate breast cancer and provide counseling. The grant drives awareness around prevention and early detection by providing support to organizations that provide direct patient care.
Researchers across campus are taking a One WVU approach to solving important problems and saving lives. At its core, an experimental therapeutics platform that integrates multiple disciplines from chemistry and biology to the health sciences and cancer institute.